On Tuesday 13 February, the European Commission announced the launch of two new projects in the field of health, one of which concerns antimicrobial resistance (AMR) and healthcare-associated infections.
The first project aims to reduce the risk of public exposure to antibiotic-resistant bacteria. It is supported by €50 million from the EU4Health programme. The JAMRAI 2 action brings together all the EU Member States as well as Iceland, Norway and Ukraine to work in areas such as infection prevention and control, surveillance and monitoring, prudent use of antimicrobials, raising awareness and innovation.
The second project focuses on the prevention of cancer and other non-communicable diseases, such as cardiovascular disease and diabetes, as well as mental health. It will be funded to the tune of €76 million by the EU4Health programme and brings together the national authorities of 22 EU Member States, as well as Norway, Iceland and Ukraine. The JA PreventNCD joint action will also make it possible to set up a comprehensive European infrastructure for monitoring factors linked to cancer and other non-communicable diseases, and to focus on reducing social inequalities. (Original version in French by Lionel Changeur)